Cargando…
Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development
SARS-CoV-2 has been marked as a highly pathogenic coronavirus of COVID-19 disease into the human population, causing over 5.5 million confirmed cases worldwide. As COVID-19 has posed a global threat with significant human casualties and severe economic losses, there is a pressing demand to further u...
Autores principales: | Zhu, Yuefei, Li, Jia, Pang, Zhiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335243/ https://www.ncbi.nlm.nih.gov/pubmed/32837565 http://dx.doi.org/10.1016/j.ajps.2020.06.001 |
Ejemplares similares
-
Coronaviruses — drug discovery and therapeutic options
por: Zumla, Alimuddin, et al.
Publicado: (2016) -
Therapeutic options in coronavirus treatment: COVID-19 drug discovery update
por: Mukherjee, Suchetana, et al.
Publicado: (2022) -
Dendrimer-Based Drug Delivery Systems for Brain Targeting
por: Zhu, Yuefei, et al.
Publicado: (2019) -
New therapeutic modalities in drug discovery and development: Insights & opportunities
por: Kansy, Manfred, et al.
Publicado: (2021) -
Molecular Insights into Coumarin Analogues as Antimicrobial Agents: Recent Developments in Drug Discovery
por: Cheke, Rameshwar S., et al.
Publicado: (2022)